Guardion Health Sciences

San Diego, United States Founded: 2009 • Age: 17 yrs Listed
Developer of clinically supported dietary supplements for ocular health

About Guardion Health Sciences

Guardion Health Sciences is a publicly listed company based in San Diego (United States) founded in 2009. Guardion Health Sciences has raised $11.14 million across 11 funding rounds from investors including Liaison Interactive and America’s Seed Fund. The company has 12 employees. Guardion Health Sciences has completed 2 acquisitions, including VectorVision and Viactiv. Its chief executive, as recorded, is Michael Favish. Guardion Health Sciences offers products and services including Dietary Supplements and Clinically Supported Products. Its focus areas include Traditional Nutraceuticals and Diversified. Its legal entity is Guardion Health Sciences, Inc.

Company details

Developer of clinically supported dietary supplements for ocular health. It develops and markets dietary supplements specifically focused on improving eye health. The products are designed to address specific consumer needs within the ocular health market and are based on clinical research and evidence. The companys mission is to provide effective nutritional solutions to help maintain eye health and overall well-being. The supplements are intended to be used as part of a broader health strategy.

  • Headquarters San Diego, United States
  • Employees 12
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website guardionhealth.com
  • Social LinkedIn X Facebook
  • Legal Name Guardion Health Sciences, Inc
Key Metrics
  • Annual Revenue
    $12.25 M (USD)
    11
    as on Dec 31, 2023
  • Net Profit
    $158.03 K (USD)
    101
    as on Dec 31, 2023
  • EBITDA
    -$4.34 M (USD)
    75
    as on Dec 31, 2023
  • Total Equity Funding
    $11.14M (USD)

    in 11 rounds

  • Latest Funding Round
    $999.69K (USD), Grant

    Aug 2020

  • Investors
  • Employee Count
    12
  • Investments & Acquisitions

Products & Services of Guardion Health Sciences

Guardion Health Sciences offers a comprehensive portfolio of products and services, including Dietary Supplements and Clinically Supported Products.

Dietary Supplements
Health Products

Dietary supplements for ocular health are developed to support benefits related to eye conditions and active lifestyles

Clinically Supported Products
Nutraceuticals

Products that are clinically supported and aimed at addressing nutrient gaps in metabolic processes are offered by Guardion Health Sciences

Funding Insights of Guardion Health Sciences

Guardion Health Sciences has successfully raised a total of $11.14M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $999.69 thousand completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $11.14M
  • Total Rounds 11
  • Last Round Grant — $999,687
  • First Round $500,000

    (May 2015)

  • Investors Count 2

Latest 10 of 11 funding rounds of Guardion Health Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2020$999,687Grant––
Mar 2020$3.51MPost-IPO––
–
Apr 2019$350,000Series B––
–
Feb 2019$223,660Grant––
Jan 2019$850,000Series B––
–
Jan 2018$5MSeries B––
Jul 2017$3.11MSeries B––
–
Mar 2017$50,000Series A––
–
Jan 2017$1.71MSeries A––
–
Mar 2016$76,000Seed––
–
Valuation history

2 investors in total: 2 institutional.

Investors in Guardion Health Sciences

Guardion Health Sciences has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Liaison Interactive and America’s Seed Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital fund backed by the US Government
seedfund.nsf.govAlexandria, United States
Provider of integrated media and entertainment services
2007lianluo.comHangzhou, China
Premium access

Investor details for Guardion Health Sciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Guardion Health Sciences

5 people are tracked at Guardion Health Sciences (2 in leadership, 3 in board & advisors); the tracked headcount is 12.

NameRoleGroup
Michael Favish
CEO & PresidentLeadership
Susan Klein
Director, Medical EducationLeadership
Donald A. Gagliano
DirectorBoard & advisors
Mark Goldstone
DirectorBoard & advisors
Robert N. Weingarten
DirectorBoard & advisors
Premium access

Complete people profiles for Guardion Health Sciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Guardion Health Sciences

Guardion Health Sciences has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include VectorVision and Viactiv.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Manufacturer of calcium and omega-3 supplements in chewable and gummy forms
viactiv.comGreenwich, United States2012May 2021$26M
Vision testing technology is provided through specialized instruments.
vectorvision.comGreenville, United States1987Mar 2017••••
Premium access

Complete acquisition details for Guardion Health Sciences

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Guardion Health Sciences

6 dated milestones of Guardion Health Sciences across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Guardion Health Sciences is founded.
  2. Funding First funding round of $500K.
  3. Acquisition Acquires VectorVision.
  4. IPO Lists on the stock exchange (IPO).
  5. Funding Latest funding round, Grant, of $1,000K.
  6. Acquisition Acquires Viactiv.

Web traffic of Guardion Health Sciences

The website of Guardion Health Sciences (guardionhealth.com) receives about 1.2K visits a month.

  • Monthly visits
    1.2K

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Guardion Health Sciences (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Guardion Health Sciences

Guardion Health Sciences was founded in 2009 and raised its 1st funding round 6 years after it was founded.

Guardion Health Sciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Michael Favish is the CEO of Guardion Health Sciences, as recorded in our data.

Guardion Health Sciences is a funded company, having raised a total of $11.14M across 11 funding rounds to date. The company's 1st funding round was a Seed of $76K, raised on May 2015.

Guardion Health Sciences has 12 employees.

Annual revenue of Guardion Health Sciences is $12.25M as on Dec 31, 2023.

Developer of clinically supported dietary supplements for ocular health. It develops and markets dietary supplements specifically focused on improving eye health. The products are designed to address specific consumer needs within the ocular health market and are based on clinical research and evidence. The companys mission is to provide effective nutritional solutions to help maintain eye health and overall well-being. The supplements are intended to be used as part of a broader health strategy.

Guardion Health Sciences offers Dietary Supplements and Clinically Supported Products.

Guardion Health Sciences has made 2 acquisitions, including VectorVision, and Viactiv.

Guardion Health Sciences has 2 investors. Key investors include Liaison Interactive, and America’s Seed Fund.

Guardion Health Sciences operates through Guardion Health Sciences, Inc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available